Billionaires Holding SRPT

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 41.5M
    Shares Outstanding

  • 1.90B
    Market Cap

News & Insights

ABOUT

SRPT

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. Its lead product candidate is Eteplirsen, an antisense phosphorodiamidate morpholino oligomer therapeutic, which i...

Germany’s Economy Revs Up

NEWS

The Morning Ledger: WTO Deadline Could Hurt Firms with Supply Chains in China

READ MORE